Niuniu Sun1, Lin Ye1, Tingmin Chang2, Xiaojing Li3, Xiumin Li4. 1. School of Nursing, Xinxiang Medical University Xinxiang 453003, China. 2. The First Affiliated Hospital of Xinxiang Medical University Xinxiang 453003, China. 3. School of Nursing, Xinxiang Medical University Xinxiang 453003, China ; Henan Nursing Vocational College Anyang 455000, China. 4. Center for Cancer Research, School of Nursing, Xinxiang Medical University Xinxiang 453003, China ; The Third Affiliated Hospital of Xinxiang Medical University Xinxiang 453003, China.
Abstract
BACKGROUND AND PURPOSE: Previous studies observed the downregulation of microRNA (miR)-195 in esophageal squamous cell carcinoma (ESCC) tissues, confirmed cell division cycle 42 (Cdc42) as one target gene of miR-195, and demonstrated that miR-195 may act as a tumor suppressor in ESCC by regulating Cdc42 expression. This study aimed to explore the association of miR-195 and Cdc42 combined expression with clinicopathologic factors and prognosis. METHODS: Expression of miR-195 and Cdc42 mRNA in 98 pairs of ESCC and paracancerous tissues were detected using real-time quantitative RT-PCR. RESULTS: miR-195 downregulation and Cdc42 upregulation were both prevalent in ESCC tissues, and negatively correlated with each other. In addition, miR-195 expression negatively correlated with TNM stage (P=0.008) and lymphatic metastasis (P=0.022), while Cdc42 expression positively correlated with TNM stage (P=0.011) and tumor differentiation (P=0.024). Moreover, combined expression of miR-195 and Cdc42 (miR-195/Cdc42) was found to be prognostic indicators for progression-free survival and overall survival of ESCC patients both in univariate and multivariate analyses. CONCLUSION: The main findings of this study indicate the involvement of miR-195-Cdc42 axis in the progression of ESCC and suggest that the combined aberrant expression of miR-195 and Cdc42 mRNA can serve as a promising unfavorable prognostic biomarker in ESCC.
BACKGROUND AND PURPOSE: Previous studies observed the downregulation of microRNA (miR)-195 in esophageal squamous cell carcinoma (ESCC) tissues, confirmed cell division cycle 42 (Cdc42) as one target gene of miR-195, and demonstrated that miR-195 may act as a tumor suppressor in ESCC by regulating Cdc42 expression. This study aimed to explore the association of miR-195 and Cdc42 combined expression with clinicopathologic factors and prognosis. METHODS: Expression of miR-195 and Cdc42 mRNA in 98 pairs of ESCC and paracancerous tissues were detected using real-time quantitative RT-PCR. RESULTS:miR-195 downregulation and Cdc42 upregulation were both prevalent in ESCC tissues, and negatively correlated with each other. In addition, miR-195 expression negatively correlated with TNM stage (P=0.008) and lymphatic metastasis (P=0.022), while Cdc42 expression positively correlated with TNM stage (P=0.011) and tumor differentiation (P=0.024). Moreover, combined expression of miR-195 and Cdc42 (miR-195/Cdc42) was found to be prognostic indicators for progression-free survival and overall survival of ESCC patients both in univariate and multivariate analyses. CONCLUSION: The main findings of this study indicate the involvement of miR-195-Cdc42 axis in the progression of ESCC and suggest that the combined aberrant expression of miR-195 and Cdc42 mRNA can serve as a promising unfavorable prognostic biomarker in ESCC.
Authors: Michio Shimizu; Giovanni Zaninotto; Koji Nagata; David Y Graham; Gregory Y Lauwers Journal: Best Pract Res Clin Gastroenterol Date: 2013-04 Impact factor: 3.043
Authors: Ming Liu; Nan Lang; Meng Qiu; Feng Xu; Qiu Li; Qiulin Tang; Ji Chen; Xi Chen; Siyuan Zhang; Zhen Liu; Jitao Zhou; Yajie Zhu; Yu Deng; Yi Zheng; Feng Bi Journal: Int J Cancer Date: 2011-03-15 Impact factor: 7.396
Authors: Jian Hua Mao; Rong Ping Zhou; Ai Fen Peng; Zhi Li Liu; Shan Hu Huang; Xin Hua Long; Yong Shu Journal: Oncol Lett Date: 2012-08-16 Impact factor: 2.967
Authors: Jaroslav Nunvar; Lucie Pagacova; Zuzana Vojtechova; Nayara Trevisan Doimo de Azevedo; Jana Smahelova; Martina Salakova; Ruth Tachezy Journal: Biomolecules Date: 2021-05-20
Authors: I Summerer; K Unger; H Braselmann; L Schuettrumpf; C Maihoefer; P Baumeister; T Kirchner; M Niyazi; E Sage; H M Specht; G Multhoff; S Moertl; C Belka; H Zitzelsberger Journal: Br J Cancer Date: 2015-06-09 Impact factor: 7.640